1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Refractory T Acute Lymphoblastic Leukemia: new trials by email Literature Review of Refractory T Acute Lymphoblastic Leukemia trials Research Report on Refractory T Acute Lymphoblastic Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to Treat Anti-CD123 ADC IMGN632, Bone Marrow Aspiration and Biopsy, Cytarabine - Recurrent Acute Myeloid Leukemia, Recurrent B Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Withdrawn | Children's Oncology Group | 2023-08-01 | 2023-09-01 |
Burkitt Lymphoma (1) · Leukemia, Biphenotypic, Acute (1) · Leukemia, Myeloid, Acute (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Infections (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Leukemia, Myeloid (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1)
Biopsy (1) · CPX-351 (1) · Cytarabine (1) · Daunorubicin (1) · Hydrocortisone (1) · Injections (1) · Liposomes (1) · Methotrexate (1) · Methylprednisolone (1) · Prednisolone (1) · fludarabine phosphate (1) · hydrocortisone hemisuccinate (1) · merphos (1)
Matthew A Kutny (1)
U10CA180886 (1)